Germany is the bigger Atopic Dermatitis Drugs market: $411 Mn against $292 Mn in 2023, about 1.4 times as large.
Germany grows faster: 10.4% a year, against 10.2%.
Clinical research: 25 active trials in the UK, 43 in Germany.
| Measure |  UK |  Germany |
|---|---|---|
| Market size, 2023 | $292 Mn | $411 Mn |
| Market size, 2033 projected | $771 Mn | $1.1 Bn |
| Growth a year (CAGR) | 10.2% | 10.4% |
| Money added, 2023–2033 | $479 Mn | $695 Mn |
| Share of the world market | 2.6% | 3.7% |
| Size rank of 24 countries | #7 | #5 |
| Market per person, 2023 | $4.20 | $4.92 |
| Active clinical trials | 25 | 43 |
| Full report | UK report | Germany report |
Year by year, 2023 to 2033
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
UK Germany · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Atopic Dermatitis Drugs, UK or Germany?
Germany is the bigger Atopic Dermatitis Drugs market: $411 Mn against $292 Mn in 2023, about 1.4 times as large.
Which grows faster in Atopic Dermatitis Drugs, UK or Germany?
Germany grows faster: 10.4% a year, against 10.2%.
More Atopic Dermatitis Drugs comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.